BCM
AXNX

BluePath Capital Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

BluePath Capital Management’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,786
Closed -$264K – 111
2024
Q3 		$264K Hold
3,786
– – 0.16% 89
2024
Q2 		$255K Sell
3,786
-80
-2% -$5.39K 0.18% 97
2024
Q1 		$267K Sell
3,866
-8
-0.2% -$540 0.2% 100
2023
Q4 		$267K Buy
3,874
+4
+0.1% +$224 0.23% 93
2023
Q3 		$217K Buy
+3,870
New +$218K 0.2% 92

Other funds holding AXNX

TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BluePath Capital Management's AXNX Position: Q4 2024 in Review

BluePath Capital Management sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 3,786 shares — an estimated $264K sold.

BluePath Capital Management first reported a position in AXNX in Q3 2023 and held it in 5 quarters. The position peaked at $267K in Q4 2023. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • BluePath Capital Management reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • BluePath Capital Management sold 3,786 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $264K.
  • BluePath Capital Management first reported a position in Axonics, Inc. Common Stock in Q3 2023 and held it in 5 quarters.
  • BluePath Capital Management's Axonics, Inc. Common Stock position peaked at $267K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on BluePath Capital Management's 13F filing for Q4 2024, filed 14 Jan 2025.